0
Your cart

Your cart is empty

Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology

Buy Now

Integration of Pharmaceutical Discovery and Development - Case Histories (Hardcover, 1998 ed.) Loot Price: R5,560
Discovery Miles 55 600
Integration of Pharmaceutical Discovery and Development - Case Histories (Hardcover, 1998 ed.): Ronald T. Borchardt, Roger M....

Integration of Pharmaceutical Discovery and Development - Case Histories (Hardcover, 1998 ed.)

Ronald T. Borchardt, Roger M. Freidinger, Tomi K. Sawyer, Philip L. Smith

Series: Pharmaceutical Biotechnology, 11

 (sign in to rate)
Loot Price R5,560 Discovery Miles 55 600 | Repayment Terms: R521 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

In the late 1980s, it became painfully evident to the pharmaceutical industry that the old paradigm of drug discovery, which involved highly segmented drug - sign and development activities, would not produce an acceptable success rate in the future. Therefore, in the early 1990s a paradigm shift occurred in which drug design and development activities became more highly integrated. This new str- egy required medicinal chemists to design drug candidates with structural f- tures that optimized pharmacological (e. g. , high affinity and specificity for the target receptor), pharmaceutical (e. g. , solubility and chemical stability), bioph- maceutical (e. g. , cell membrane permeability), and metabolic/pharmacokinetic (e. g. , metabolic stability, clearance, and protein binding) properties. Successful implementation of this strategy requires a multidisciplinary team effort, incl- ing scientists from drug design (e. g. , medicinal chemists, cell biologists, en- mologists, pharmacologists) and drug development (e. g. , analytical chemists, pharmaceutical scientists, physiologists, and molecular biologists representing the disciplines of pharmaceutics, biopharmaceutics, and pharmacokinetics/drug metabolism). With this new, highly integrated approach to drug design now widely utilized by the pharmaceutical industry, the editors of this book have provided the sci- tific community with case histories to illustrate the nature of the interdisciplinary interactions necessary to successfully implement this new approach to drug d- covery. In the first chapter, Ralph Hirschmann provides a historical perspective of why this paradigm shift in drug discovery has occurred.

General

Imprint: Kluwer Academic / Plenum Publishers
Country of origin: United States
Series: Pharmaceutical Biotechnology, 11
Release date: August 1998
First published: 1998
Editors: Ronald T. Borchardt • Roger M. Freidinger • Tomi K. Sawyer • Philip L. Smith
Dimensions: 229 x 152 x 39mm (L x W x T)
Format: Hardcover
Pages: 610
Edition: 1998 ed.
ISBN-13: 978-0-306-45743-2
Categories: Books > Science & Mathematics > Biology, life sciences > Zoology & animal sciences > Animal physiology
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 0-306-45743-1
Barcode: 9780306457432

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners